Knowledge and practices regarding infant vaccination: results of a survey of French physicians

被引:0
作者
Pierre Bakhache
Brigitte Virey
Christina Bienenfeld
机构
[1] AFPA,
[2] Association Française de Pédiatrie Ambulatoire,undefined
[3] INFOVAC,undefined
[4] IFOP Healthcare,undefined
来源
European Journal of Pediatrics | 2019年 / 178卷
关键词
Fully liquid vaccine; General practitioner; Hexavalent vaccine; Pediatrician vaccine reconstitution;
D O I
暂无
中图分类号
学科分类号
摘要
A prospective, observational, survey of pediatricians and general practitioners (GPs) was conducted to assess pediatric vaccination knowledge and practices. The survey was distributed by email to 1069 pediatricians and 1700 GPs and completed by 151 pediatricians (14.1%) and 201 GPs (11.8%). Knowledge of the vaccination calendar was very good (99% overall). Of the respondents, 98% were confident in vaccine efficacy. Eight-one percent of pediatricians and 62% of GPs agreed that recommended vaccinations should become obligatory; all prescribed hexavalent vaccines often or always. More pediatricians (88%) than GPs (75%) used anti-pyretics; the use of anesthetic cream/patches was similar in each group (79% and 75%, respectively). The ambience at vaccination was considered to be important by both groups, and was disturbed in 37% of cases. Seventy percent of pediatricians and 57% of GPs agreed that vaccine reconstitution (e.g., Hib pellet) is a complicating factor: overall, 28% reported occasionally omitting to reconstitute a pentavalent or hexavalent vaccine in error, and 60% reported having not fully reconstituted the vaccine. Almost all (93%) considered non-reconstitution as an important error.
引用
收藏
页码:533 / 540
页数:7
相关论文
共 52 条
  • [1] Das RR(2014)The effect of prophylactic antipyretic administration on post-vaccination adverse reactions and antibody response in children: a systematic review PLoS One 9 e106629-3982
  • [2] Panigrahi I(2015)Assessment of preparation time with fully-liquid versus non-fully liquid paediatric hexavalent vaccines. A time and motion study Vaccine 33 3976-512
  • [3] Naik SS(2006)The use of combination vaccines has improved timeliness of vaccination in children Pediatr Infect Dis J 25 507-335
  • [4] De Coster I(2013)DTaP-IPV-Hep B-Hib vaccine (Hexyon®/Haxacima®): a guide to its use in the primary and booster vaccination of infants and toddlers in Europe Drugs Ther Perspect 29 329-500
  • [5] Fournie X(2007)Use of combination vaccines is associated with improved coverage rates Pediatr Infect Dis J 26 496-70
  • [6] Faure C(2013)DTaP-IPV-Hep B-Hib vaccine (Hexaxim®): a review of its use in primary and booster vaccination Paediatr Drugs 15 59-93
  • [7] Ziani E(2004)Clinician satisfaction with vaccination visits and the role of multiple injections, results from the COVISE study (combination vaccines impact on satisfaction and epidemiology) Clin Pediatr (Phila) 43 87-1005
  • [8] Nicolas L(2011)A DTaP-IPV//PRP~T vaccine (Pentaxim): a review of 16 years' clinical experience Expert Rev Vaccines 10 981-648
  • [9] Soubeyrand B(1994)Use of lidocaine-prilocaine cream for vaccination pain in infants J Pediatr 124 643-721
  • [10] Kalies H(1993)A eutectic mixture of lidocaine and prilocaine for alleviating vaccination pain in infants Pediatrics 92 719-849